The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quantitative Ki-67 score as predictive of response to neoadjuvant chemotherapy in breast cancer.
Jason R. Brown
No relevant relationships to disclose
Donald R. Lannin
No relevant relationships to disclose
Brigid K. Killelea
No relevant relationships to disclose
Michael DiGiovanna
No relevant relationships to disclose
David Rimm
Consultant or Advisory Role - Genoptix